Rare sleep genetics explain the people who wake after four hours and still function
Some people really do wake up after four or five hours of sleep feeling alert, energetic, and ready to move. For most adults, that is not a survivable routine without cost. For a small group, it appears to be the baseline biology they were born with.
Aimee Pugh Bernard, an immunology professor at the University of Colorado, is one of them. She typically goes to bed around 22:00 and wakes around 04:30, often without an alarm and without the drag that most sleep-deprived adults would expect. In her case, the pattern runs in the family, with her father and brother showing the same short-sleep tendency. Genetic testing later linked her to a rare inherited variant associated with familial natural short sleep, or FNSS.
This is not ordinary insomnia dressed up as resilience. FNSS describes a heritable pattern in which people regularly sleep only four to six and a half hours a night while remaining apparently well rested and functioning normally during the day. The condition has become a useful window into the biology of sleep itself, because it raises an unusually direct question: what separates true short sleepers from everyone else who simply tries to get by on too little rest?
Family traits and rare mutations point to a distinct sleep biology
The first clues came from rare mutations rather than broad population studies. In 2019, a research team at the University of California, San Francisco identified a mutation tied to shorter sleep duration in humans. Bernard later sent a blood sample and learned she carried one of those variants. Since then, several other mutations linked to FNSS have been described.
What makes these findings clinically intriguing is not only that the carriers sleep less. The deeper question is whether they are also protected from the usual consequences of curtailed sleep. In laboratory experiments, that possibility has started to look plausible. One mouse study found that introducing an FNSS-related mutation reduced sleep time while also appearing to shield the animals from memory deficits. Another mouse model suggested a lower likelihood of developing an Alzheimer’s-like phenotype.
Human data have pointed in a similar direction. In a study of fraternal twins, one carrying a short-sleep mutation and the other not, the carrier slept about an hour less on a regular basis. When both twins were kept awake for 38 hours, the carrier showed about 40% fewer performance lapses. Even their sleep architecture looked somewhat different. Despite sleeping less, the mutation carrier had nearly the same amount of non-REM sleep as his brother, including slow-wave sleep, the stage most closely associated with deep restorative sleep. In effect, the carrier may have been compressing sleep more efficiently rather than merely tolerating deprivation better.
A single sentence captures the clinical challenge: short sleep is not always short sleep disorder.
Common variants may shift sleep duration in smaller but measurable ways
The rare FNSS mutations are only part of the story. Sleep duration appears to be substantially heritable overall, with estimates ranging from 30% to 65%. Hundreds of genomic regions have been implicated in how long people sleep, and a new analysis of data from nearly 650,000 adults identified around 244 relevant sites, though that work remains unpublished and in preprint.
Most of those common variants have tiny individual effects. A single one may shift sleep duration by about a minute. Combined across the genome, however, the differences can add up. Isabelle Austin-Zimmerman, a geneticist at King’s College London and lead author of the preprint analysis, estimated that genetic differences may account for about 20 minutes of variation in sleep duration for the average person.
Even those modest effects matter because sleep is not a single trait. Duration, efficiency, resilience to sleep loss, and vulnerability to daytime impairment do not always move together. Someone may sleep a little less by nature and feel fine. Another person may sleep the same number of hours and still show marked cognitive decline after restriction. The biology behind that split is still being mapped.
Short-sleep genetics may protect some people and burden others
The most interesting recent human data suggest that some genetic short-sleep profiles may reduce vulnerability in specific settings. A study led by Chiara Petrosellini at University College London examined 343 women with bipolar disorder who had given birth. The investigators scored participants for their genetic likelihood of being short sleepers, based on suspected variants associated with that trait. Women with the highest short-sleep scores had half the risk of postpartum psychosis compared with women with the lowest scores. The same pattern appeared for insomnia.
The most plausible explanation is not that short sleep is universally beneficial, but that some people may have developed a degree of resistance to sleep disruption long before pregnancy. If so, their nervous systems may be less destabilized by the sleep fragmentation and circadian strain that often follow childbirth. Postpartum psychosis remains a severe psychiatric emergency, so any biologic clue that helps explain susceptibility deserves close attention.
Yet the genetic picture is not uniformly reassuring. In larger population analyses not limited to mothers with bipolar disorder, variants associated with shorter sleep have been linked with a higher risk of insomnia and feeling tired. They have also been associated with several mental and physical health conditions, including ADHD, depressive symptoms, and type 2 diabetes. Those associations do not prove causation, but they do show that a short-sleep genetic signature is not automatically protective.
Subjective alertness can be a dangerous guide
One of the biggest clinical traps in sleep medicine is self-assessment. People who are chronically short on sleep often feel as though they have adapted, even as objective performance deteriorates. In one study of healthy adults restricted to four or six hours in bed per night, cognitive performance worsened steadily over time. Yet by the second week, participants rated themselves as only slightly sleepy.
Hans van Dongen, a sleep scientist at Washington State University’s Sleep and Performance Research Center and a co-author of that work, described the pattern plainly: impairment accumulates, and awareness of the impairment drops. That matters in daily life, in the workplace, and in settings where fatigue can be dangerous. Sleep loss is not always felt as sleepiness. Sometimes it shows up first as slowed reaction time, attention lapses, mood change, or reduced judgment.
Some people are genuinely more resilient to sleep deprivation than others, and van Dongen’s work has helped establish that point. The harder question is how to identify the minority whose short sleep is biologically normal, versus the much larger group who think they are functioning well while their performance quietly erodes.
What these findings could change in treatment and drug development
Interest in the genetics of short sleep is increasing because the field could eventually translate into therapy. In theory, a better understanding of FNSS and other short-sleep variants could inform drugs for insomnia, shift-work fatigue, or even extreme operational settings such as military duty. The appeal is obvious: if scientists can learn why certain people sleep less without paying the usual physiologic price, that pathway might be harnessed for patients who currently struggle with sleep deficiency.
The risk is equally obvious. Manipulating sleep biology without understanding the downstream effects could create a treatment that reduces sleep time but opens the door to neurodegeneration, psychiatric harm, or other long-term complications. Ying-Hui Fu, the molecular biologist leading much of this work, has emphasized that any intervention must explain its mechanism first. A drug that changes sleep without revealing how it alters memory, metabolism, or neurologic resilience would be an unsafe leap.
Bernard’s own experience captures the human side of the science. Learning that she carried an FNSS-linked variant removed a layer of uncertainty. She had wondered whether she was simply bad at relaxing or overcommitted. Instead, the finding gave a genetic explanation for a lifelong pattern and a practical benefit: more usable hours before her family wakes up. Even so, the broader clinical value of these discoveries will depend on whether researchers can separate harmless short sleep from short sleep that masks risk, especially when sleep loss intersects with mood disorders, cognition, and long-term metabolic health.